FDA OKs Expanded Indication for Vidaza
[ Price : $8.95]
FDA approves an expanded indication for Celgene Corp.s Vidaza (azacitidine) based on new overall survival data.
Fast Track for Amag Pharma Contrast Agent
[ Price : $8.95]
FDA grants a fast track designation to Amag Pharmaceuticals for ferumoxytol and its development as a diagnostic agent for vascular...
Vytorin Cancer Risk Probed
[ Price : $8.95]
Reps. Dingell and Stupak ask Merck/Schering-Plough for information on three Vytorin studies and relationships with the Oxford Univ...
